Tumori Journal

Papers
(The TQCC of Tumori Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer48
Small tongue squamous cell carcinoma with neck metastasis at diagnosis: operative insights and surgical technique35
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis24
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval22
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age21
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide20
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort18
Fertility preservation strategies for patients with lymphoma: a real-world practice survey among Fondazione Italiana Linfomi centers15
Oral vinorelbine in young patients with desmoid-type fibromatosis13
PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells13
Blooming in the rain12
Delta-volume radiomics of induction chemotherapy to predict outcome of subsequent chemoradiotherapy for locally advanced hypopharyngeal cancer12
“Based on a true story” podcast: a journey into the world of young patients with cancer11
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia11
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis11
Chemo-surgical approach in vulvar leiomyosarcoma: A case report11
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach11
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study9
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network8
Advances in spatial multi-omics in tumors8
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement8
Successful retreatment with erlotinib after erlotinib-related interstitial lung disease8
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma8
Expression of concern8
Prognostic value of Aurora B expression in cancer patients: A meta-analysis7
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-20177
Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy7
Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testing7
Volumetric staging in radiotherapy for oropharyngeal cancers7
Humanistic nursing combined with Neuman’s nursing in the application for oncology patients7
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients6
Personalized treatment using predictive biomarkers in solid organ malignancies: A review6
Adherence to oral hormonal anticancer agents in breast cancer6
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer6
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study6
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects5
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization5
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update5
Quality assurance for cancer patient safety: Clinical assessment for precise angles in linac during radiation therapy5
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC5
ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma5
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series5
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer5
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes5
KRAS inhibitors in drug resistance and potential for combination therapy4
Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families4
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study4
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?4
A single-center experience with giant cell tumors of sphenoid bone and clivus4
BGICC Conference Abstract Book 20224
15th BGICC Abstract Book 20234
Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors4
Current practices of follow-up programs for childhood cancer survivors in Italy4
Prolonged COVID-19 infection in a child with lymphoblastic non-Hodgkin lymphoma: which is the best management?4
AIOM Abstract4
Comparative analysis of the quantitative parameter method and elasticity color mode method for real-time shear wave elastography in the diagnosis of benign and malignant solid breast lesions4
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience4
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease4
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report4
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?4
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology4
Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis4
Risk-based breast cancer screening: What are the challenges?3
Neuroanatomical changes seen in MRI in patients with cerebral metastasized breast cancer after radiotherapy3
The digital revolution in pathology: Towards a smarter approach to research and treatment3
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice3
End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance3
Differences in clinical features and prognosis between orbit adenoid cystic carcinoma and adenocarcinoma: a study from the SEER 18 database3
Increased expression of FGF14 and SCN2A/SCN11A is associated with better survival of HCC patients3
Mediastinal lymph node removal ameliorates cytotoxic T-lymphocyte functions in patients with non-small cell lung cancer3
Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup3
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic review3
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs3
Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models3
Multidimensional mechanisms of metformin in cancer treatment3
Successful treatment of multiple relapsed–refractory Langerhans cell histiocytosis with cyclosporine3
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma3
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series3
Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scores3
Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects3
Implementation of a MSRE ddPCR method for the detection of methylated WIF1 and NPY genes in colorectal cancer patients3
De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?3
I was only sixteen3
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making3
Italian translation, cultural adaptation and pilot testing of Psychosocial Assessment Tool (PAT 3.1) in pediatric cancer3
COVID-19 immunization in people with cancer—Is it safe and efficient? What do we know?3
A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy3
Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group3
ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China3
0.18667697906494